Safety in the Rapid sequence intubation recommended in COVID-19: Experience report
DOI:
https://doi.org/10.15649/cuidarte.1260Keywords:
Coronavirus Infections, Rapid Sequence Induction and Intubation, Potentially Inappropriate Medication List, Evidence-Based Nursing, Patient SafetyAbstract
Objetive: To describe the experience regarding the strategy implemented to enhance safety during the administration of hazardous drugs recommended for rapid sequence intubation in patients with COVID-19. Materials and Methods: A descriptive experience-reporting study was conducted based on the principles of the National Patient Safety Policy, which describe the adequacy of color-coded trays for administering hazardous drugs during the rapid sequence intubation. According to the sequence of drug administration, drugs are classified into their therapeutic class in color-coded trays. The strategy was implemented in partnership with the ICU multidisciplinary team from a public cardiovascular hospital in Rio de Janeiro. Results: Color-coded trays were used three times during the rapid sequence intubation. A table was prepared based on this strategy which contained pharmacological and nursing care characteristics of hazardous drugs available in the medication preparation room for consultations. Medication Without Harm is included in the third WHO Global Patient Safety Challenge. Among the factors that contribute to the incidence of adverse effects is the use of hazardous drugs. The application of safety barriers is the strategy outlined in this report, which is necessary for the prevention of adverse effects. Conclusions: The use of color-coded trays set up barriers to the occurrence of possible incidents derived from the use of hazardous drugs during the rapid sequence intubation in patients with COVID-19
How to cite this article: Franco, Andrezza Serpa; Henrique, Danielle de Mendonça; Almeida, Luana Ferreira; Prado, Lilian Moreira; Gomes, Roberta Varzem Schwenck; Silva, Roberto Carlos Lyra. Segurança na intubação de sequência rápida recomendada no COVID-19: Relato de experiência. Revista Cuidarte. 2020; 11(2): e1260. http://dx.doi.org/10.15649/cuidarte.1260
References
BRASIL. Ministério da Saúde. Secretaria de Atenção Especializada à Saúde. Departamento de Atenção Hospitalar, Domiciliar e de Urgência. Protocolo de Manejo Clínico da Covid-19 na Atenção Especializada. 1. ed. rev. Brasília (Brasil): Ministério da Saúde; 2020.
World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected. Interim guidance. Geneva: World Health Organization; 2020.
Liao X, Wang B, Kang Y. Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units - the experience in Sichuan Province, China. Intensive Care Med. 2020; 46(2): 357–360. https://doi.org/10.1007/s00134-020-05954-2
Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–1242. https://doi.org/10.1001/jama.2020.2648
Associação Brasileira de Medicina de Emergência (ABRAMED), Associação de Medicina Intensiva Brasileira (AMIB). Protocolo de intubação orotraqueal p/ caso suspeito ou confirmado de COVID-19. ABRAMED, AMIB;2020.
Zuo MZ, Huang YG, Ma WH, Xue ZG, Zhang JQ, Gong YH, et al. Chinese Society of Anesthesiology Task Force on Airway Management. Expert Recommendations for Tracheal Intubation in Critically ill Patients with Noval Coronavirus Disease 2019.Chin Med Sci J. 2020. https://doi.org/10.24920/003724
Wahlen BM, El-Menyar A, Asim M, Al-Thani H. Rapid sequence induction (RSI) in trauma patients: Insights from healthcare providers. World J Emerg Med. 2019;10(1):19‐26. https://doi.org/10.5847/wjem.j.1920-8642.2019.01.003
Associação de Medicina Intensiva Brasileira (AMIB). Recomendações da Associação de Medicina Intensiva Brasileira para a abordagem do COVID-19 em medicina intensiva. AMIB;2020.
Stollings JL, Diedrich DA, Oyen LJ, Brown DR. Rapid-sequence intubation: a review of the process and considerations when choosing medications. Ann Pharmacother. 2014; 48(1): 62-76. https://doi.org/10.1177/1060028013510488
Sakles JC, Douglas MJK, Hypes CD, Patanwala AE, Mosier JM. Management of Patients with Predicted Difficult Airways in an Academic Emergency Department. J Emerg Med. 2017; 53(2):161-173. https://doi.org/10.1016/j.jemermed.2017.04.003
Brown III CA, Walls RM. Rapid sequence intubation. In: The Walls Manual of Emergency Airway Management, 5, Brown III CA, Sakles JC, Mick NW (Eds), Wolters Kluwer, Philadelphia 2018. p.235.
Instituto de Práticas Seguras de Medicação (ISMP). Medicamentos potencialmente perigosos de uso hospitalar - lista atualizada 2019. Boletim ISMP 2019; 8 (1).
BRASIL. Ministério da Saúde. Portaria nº 529 de 1º de abril de 2013. Institui oPrograma Nacional de Segurança do Paciente. Diário Oficial da União, Brasília: MS, 2013a.
Alpendre FT, Batista J, Gaspari AP, Dyniewicz AM, Cruz EDA. Ciclo PDCA para elaboração de checklist de segurança cirúrgica. Cogitare Enferm. 2017;(22)3: e50964. http://dx.doi.org/10.5380/ce.v22i3.50964
Henrique DM, Silva LD, Camerini FG, Andrade KBS, Pereira SRM, Fassarella CS. Aprazamento seguro da terapia analgésica com opioides no paciente queimado: um estudo transversal. Rev enferm UERJ. 2017;25:e28082. https://doi.org/10.12957/reuerj.2017.28082
BRASIL. Ministério da Saúde. Bulário Eletrônico da Agência Nacional de Vigilância Sanitária. ANVISA. Ministério da Saúde; 2020.
World Health Organization. Medication Without Harm - Global Patient Safety Challenge on Medication Safety. Geneva: World Health Organization, 2017.
World Health Organization. Mental Health and Psychosocial Considerations During COVID-19 Outbreak. Geneva: World Health Organization, 2020.
Reis MAS, Gabriel CS, Zanetti ACB, Bernardes A, Laus AM, Pereira LRL. Medicamentos potencialmente perigosos: identificação de riscos e barreiras de prevenção de erros em terapia intensiva. Texto Contexto Enferm, 2018; 27(2):e5710016. http://dx.doi.org/10.1590/0104-07072018005710016
Kothari D, Agrawal J. Color coded syringe labels: A modification to enhance patient safety. BJA: British Journal of Anaesthesia, 2013; 111(22). https://doi.org/10.1093/bja/el_9759
Souza N M G, Silva V M, Lopes M V O, Diniz C M, Ferreira G L. Avaliação da rotulagem com código de cores para identificação de medicamentos endovenosos. Rev Bras Enferm. 2019; 72( 3 ): 715-720. https://doi.org/10.1590/0034-7167-2018-0242
Published
How to Cite
Issue
Section
Altmetrics
Downloads
License
Journal Cuidarte, scientific publication of open access, is licensed under a Creative Commons Attribution (CC BY-NC), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Any other form of use such as reproduction, transformation, public communication or distribution, for profit, requires the prior authorization of the University of Santander UDES.
The names and e-mail addresses entered in the Journal Cuidarte will be used exclusively for the purposes stated by this magazine and will not be available for any other purpose or other person.
The articles published in the Journal Cuidarte represent the criteria of their authors and do not necessarily constitute the official opinion of the University of Santander UDES.
